Skip to content

Preoperative CHG Cloth on Healthy Subjects

Assessment of the Antimicrobial Efficacy of 2% CHG Cloth Preoperative Skin Preparation

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02291601
Enrollment
879
Registered
2014-11-14
Start date
2014-10-31
Completion date
2015-09-30
Last updated
2021-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Keywords

Preoperative surgical skin preparation

Brief summary

Evaluate the effects of CHG cloth on the reduction of bacteria on the skin.

Detailed description

Examine the antimicrobial cloth effects on normal flora bacteria of the abdomen and groin area post CHG application.

Interventions

DRUGChlorhexidine Gluconate

comparison with other CHG products

OTHERVehicle

Excipients of CHG product only.

2% CHG solution

Sponsors

Medline Industries
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males or Females * 16 years of age or older * Signed informed consent * Good Health * Six inches of abdomen and groin areas without tattoos, or skin disorders

Exclusion criteria

* Dermatological Conditions * Sensitivity to latex * Sensitivity to CHG

Design outcomes

Primary

MeasureTime frameDescription
Percent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites10 minutes to 8 hoursPercent of abdomen and groin sites that achieve a 2-Log or 3-Log reduction respectively of bacterial flora from baseline. Note: The number of participants in each treatment group (abdomen and/or groin) can vary depending on whether participants achieved qualifying microbial levels on the abdomen and groin at baseline.

Countries

United States

Participant flow

Recruitment details

Upon achieving sufficient microbial growth prior to product application on either the abdomen, groin or both abdomen and groin regions, sites of the participant were then randomized to receive one or two products for evaluation for up 4 sites. Differences in the number of participants is based on microbial qualification.

Pre-assignment details

The sites of the participant were tested for microbial activity after product application. In some instances, more than one product could have been applied to a participant but only one product per site (groin and/or abdomen sites). Up to 4 sites could be treated : 1) both groin and abdomen, 2) only the groin or 3) only the abdomen.

Participants by arm

ArmCount
CHG, Vehicle, Comparator CHG
Single applications of products. 3 min application for CHG and vehicle. Comparator CHG applied according to instructions.
879
Total879

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
AbdomenDid not qualify33354339
GroinDid not qualify18330177

Baseline characteristics

CharacteristicCHG, Vehicle, Comparator CHG
Age, Categorical
<=18 years
13 Participants
Age, Categorical
>=65 years
37 Participants
Age, Categorical
Between 18 and 65 years
829 Participants
Age, Continuous35 years
Region of Enrollment
United States
879 participants
Sex: Female, Male
Female
281 Participants
Sex: Female, Male
Male
598 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
16 / 7554 / 1368 / 753
serious
Total, serious adverse events
0 / 7550 / 1360 / 753

Outcome results

Primary

Percent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites

Percent of abdomen and groin sites that achieve a 2-Log or 3-Log reduction respectively of bacterial flora from baseline. Note: The number of participants in each treatment group (abdomen and/or groin) can vary depending on whether participants achieved qualifying microbial levels on the abdomen and groin at baseline.

Time frame: 10 minutes to 8 hours

Population: Participants received 1 or 2 products on up to 2 abdomen and 2 groin sites, 2 abdomen only sites or 2 groin sites only.

ArmMeasureGroupValue (NUMBER)
CHG AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites6 hours99 % of Treated Sites
CHG AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites10 min80 % of Treated Sites
CHG AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites8 hours98 % of Treated Sites
CHG GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites6 hours100 % of Treated Sites
CHG GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites10 min75 % of Treated Sites
CHG GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites8 hours100 % of Treated Sites
Vehicle AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites6 hours97 % of Treated Sites
Vehicle AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites10 min86 % of Treated Sites
Vehicle AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites8 hours97 % of Treated Sites
Vehicle GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites6 hours100 % of Treated Sites
Vehicle GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites10 min65 % of Treated Sites
Vehicle GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites8 hours100 % of Treated Sites
Comparator AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites6 hours96 % of Treated Sites
Comparator AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites10 min81 % of Treated Sites
Comparator AbdomenPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites8 hours96 % of Treated Sites
Comparator GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites10 min68 % of Treated Sites
Comparator GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites8 hours100 % of Treated Sites
Comparator GroinPercent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites6 hours100 % of Treated Sites

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026